<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03172858</url>
  </required_header>
  <id_info>
    <org_study_id>STU00203535</org_study_id>
    <nct_id>NCT03172858</nct_id>
  </id_info>
  <brief_title>Randomized Control Trial of Intracervical Balloon Placement vs Oxytocin in Women With Term PROM and Unripe Cervices</brief_title>
  <official_title>A Randomized Trial of Intracervical Balloon Placement Versus Intravenous Oxytocin in Women With Premature Rupture of Membranes and Unripe Cervices</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Northwestern University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Northwestern University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is designed to determine if an intracervical balloon catheter (IBC) is better than
      oxytocin for induction of labor in the setting of premature rupture of membranes (PROM) or
      breaking the bag of water prior to onset of labor. The investigators suspect that an
      intracervical balloon catheter will shorten the time interval from initiation of induction of
      labor to delivery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      There are not enough studies to support the use of intracervical balloon catheter (IBC) use
      in term premature rupture of membranes (PROM). Prospective randomized studies comparing IBC
      placement to oxytocin use in induction of labor for term PROM do not exist. Intracervical
      Balloon Catheter has been shown to reduce duration of labor for women with intact membranes
      undergoing induction of labor. The practice at this institution is to use oxytocin to start
      contractions when a woman has PROM. This study will examine IBC compared to oxytocin use in
      term PROM. This will allow for the evaluation of a cervical ripening method for term PROM
      that may improve women's outcomes. Other outcomes for this study are rates of infection
      during labor, cesarean section, and adverse maternal and/or neonatal outcomes.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">July 2017</start_date>
  <completion_date type="Anticipated">January 2020</completion_date>
  <primary_completion_date type="Anticipated">January 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>randomized controlled trial</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time from start of induction defined as time of IBC (intracervical balloon catheter) placement or initiation of oxytocin until delivery in hours</measure>
    <time_frame>24-48 hours/duration of induction of labor</time_frame>
    <description>length of induction</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Length of first stage of labor</measure>
    <time_frame>delivery (from initial cervical dilation to 10 cm cervical dilation])</time_frame>
    <description>length of first stage of labor</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cesarean delivery rate</measure>
    <time_frame>24-48 hours/duration of induction of labor</time_frame>
    <description>number of cesarean deliveries</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>chorioamnionitis</measure>
    <time_frame>24-48 hours/duration of induction of labor</time_frame>
    <description>Maternal temperature &gt;100.4 F during labor with associated maternal or fetal tachycardia</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Endometritis</measure>
    <time_frame>from time of delivery until 2 days after delivery for vaginal deliveries and 3 days after delivery for cesarean sections</time_frame>
    <description>temperature &gt;100.4 F in the postpartum period with initiation of antibiotics in postpartum period</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postpartum hemorrhage</measure>
    <time_frame>at time of delivery and up to 24 hours after delivery</time_frame>
    <description>Estimated blood loss (EBL) &gt;500 cc from a vaginal delivery and EBL &gt;1000 cc from a cesarean delivery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Epidural use</measure>
    <time_frame>24-48 hours/duration of induction of labor</time_frame>
    <description>epidural anesthesia use during labor</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neonatal 5-minute Apgar score</measure>
    <time_frame>5 minutes after delivery</time_frame>
    <description>apgar score at 5 minutes of life after delivery of neonate</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neonatal umbilical arterial and venous acid base status</measure>
    <time_frame>at the time of delivery</time_frame>
    <description>assessment of acid-base status of neonate at the time of delivery</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Premature Rupture of Membrane</condition>
  <condition>Unfavorable Cervix</condition>
  <arm_group>
    <arm_group_label>Intracervical Balloon Catheter Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The intracervical balloon catheter will be passed through the cervix either with a speculum exam or by a digital exam. Then the catheter balloon will be filled with 80 cc of sterile fluid. The catheter will be pulled to tension and taped to the patient's leg.
Patients will have the option to IV pain medication at the time of intracervical balloon placement. The intracervical balloon will remain in place for 6 hours unless it falls out spontaneously. At the 6 hour mark, a vaginal exam will assess if the intracervical balloon has pulled through the cervix or if it needs further tension. The intracervical balloon will remain in place a maximum of 12 hours. After a maximum of 12 hours in place the intracervical balloon will be removed and oxytocin will be started per protocol.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Immediate low-dose oxytocin infusion group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>At our institution the policy for oxytocin infusion is to start at a low dose of 2mu/min and to increase by 2mu/min at 15 to 20 minute intervals based on how often uterine contractions are occuring. A specific order from a physician is required to increase the oxytocin dose above 20 mu/min. Oxytocin will be titrated per usual protocol.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Intracervical balloon catheter</intervention_name>
    <description>cervical ripening balloon</description>
    <arm_group_label>Intracervical Balloon Catheter Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Oxytocin</intervention_name>
    <description>medication used to induce contractions</description>
    <arm_group_label>Intracervical Balloon Catheter Group</arm_group_label>
    <arm_group_label>Immediate low-dose oxytocin infusion group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Nulliparous women, Women aged 18-50 years, Singleton gestation, Vertex presentation, Live
        fetus, Rupture of membranes confirmed by sterile speculum examination &gt; 37 weeks of
        gestation at time of rupture of membranes, Bishop score &lt; 6

        Exclusion Criteria:

        Multiparous women, Bishop score &gt;6, Multifetal gestation, Contraindication to labor
        including placenta previa , Maternal fever prior to randomization: T &gt;100.4 F , Known fetal
        anomalies
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>pregnancy</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Whitney You, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Northwestern University</affiliation>
  </overall_official>
  <reference>
    <citation>Hannah ME, Ohlsson A, Farine D, Hewson SA, Hodnett ED, Myhr TL, Wang EE, Weston JA, Willan AR. Induction of labor compared with expectant management for prelabor rupture of the membranes at term. TERMPROM Study Group. N Engl J Med. 1996 Apr 18;334(16):1005-10.</citation>
    <PMID>8598837</PMID>
  </reference>
  <reference>
    <citation>Bond DM, Middleton P, Levett KM, van der Ham DP, Crowther CA, Buchanan SL, Morris J. Planned early birth versus expectant management for women with preterm prelabour rupture of membranes prior to 37 weeks' gestation for improving pregnancy outcome. Cochrane Database Syst Rev. 2017 Mar 3;3:CD004735. doi: 10.1002/14651858.CD004735.pub4. Review.</citation>
    <PMID>28257562</PMID>
  </reference>
  <reference>
    <citation>Mackeen AD, Walker L, Ruhstaller K, Schuster M, Sciscione A. Foley catheter vs prostaglandin as ripening agent in pregnant women with premature rupture of membranes. J Am Osteopath Assoc. 2014 Sep;114(9):686-92. doi: 10.7556/jaoa.2014.137.</citation>
    <PMID>25170038</PMID>
  </reference>
  <reference>
    <citation>Cabrera IB, Qui√±ones JN, Durie D, Rust J, Smulian JC, Scorza WE. Use of intracervical balloons and chorioamnionitis in term premature rupture of membranes. J Matern Fetal Neonatal Med. 2016 Mar;29(6):967-71. doi: 10.3109/14767058.2015.1027191. Epub 2015 Sep 25.</citation>
    <PMID>25845274</PMID>
  </reference>
  <verification_date>June 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 19, 2017</study_first_submitted>
  <study_first_submitted_qc>May 30, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">June 1, 2017</study_first_posted>
  <last_update_submitted>June 12, 2017</last_update_submitted>
  <last_update_submitted_qc>June 12, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">June 14, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Northwestern University</investigator_affiliation>
    <investigator_full_name>Whitney You</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>cervical ripening</keyword>
  <keyword>term premature rupture of membrane</keyword>
  <keyword>intracervical balloon catheter</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Premature Birth</mesh_term>
    <mesh_term>Rupture</mesh_term>
    <mesh_term>Fetal Membranes, Premature Rupture</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Oxytocin</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

